Allergy and Immunology

Allergy and immunology practice increasingly relies on standardized, validated scoring instruments to track disease activity objectively over time. Tools like the Urticaria Activity Score (UAS7) enable clinicians to quantify wheal and pruritus severity in chronic spontaneous urticaria, directly guiding step-up therapy with second-generation antihistamines, omalizumab, or cyclosporine as recommended by the EAACI/GA2LEN/EDF guidelines.

The Asthma Control Test (ACT) and its variants provide a validated patient-reported measure of asthma symptom control, correlating with specialist assessment and lung function. These tools are essential for aligning treatment with GINA strategy recommendations, particularly when deciding between step-up and step-down approaches in inhaled corticosteroid therapy.

In allergic rhinitis, the Total Nasal Symptom Score (TNSS) offers a simple, reproducible method for assessing nasal congestion, sneezing, rhinorrhea, and pruritus in clinical trials and daily practice. Immunotherapy dosing and venom allergy grading (Mueller) follow standardized protocols to minimize anaphylaxis risk during desensitization.